Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village

Investigative Ophthalmology and Visual Science

Volumn 48, Issue 4, 2007, Pages 1492-1497

  West, Sheila K ^a   Munoz, Beatriz ^a   Mkocha, Harran ^b   Gaydos, Charlotte ^c   Quinn, Thomas ^c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c Kongwa Trachoma Project   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; TETRACYCLINE; ANTIINFECTIVE AGENT; EYE DROPS;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL VIRULENCE; CHILD; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; ENDEMIC DISEASE; EYE INFECTION; FOLLOW UP; HUMAN; INFANT; INFECTION RATE; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; SINGLE DRUG DOSE; TANZANIA; TRACHOMA; CONJUNCTIVITIS; FEMALE; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; ORAL DRUG ADMINISTRATION; PRESCHOOL CHILD; RETREATMENT; RURAL POPULATION; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CHILD; CHILD, PRESCHOOL; CHLAMYDIA TRACHOMATIS; CONJUNCTIVITIS, INCLUSION; ENDEMIC DISEASES; FEMALE; HUMANS; INFANT; MALE; OPHTHALMIC SOLUTIONS; RETREATMENT; RURAL POPULATION; TANZANIA; TETRACYCLINE; TRACHOMA;

EID: 34248387697     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.06-0625     Document Type: Article

References (14)

1. Resnikoff S, Pascolini D, Etya'ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Org. 2004;82: 844-851.
2. Schachter J, West SK, Mabey D, et al. Azithromycin in control of trachoma. Lancet. 1999;354:630-635.
3. Solomon AW, Holland MJ, Alexander ND, et al. Mass treatment with single-dose azithromycin for trachoma. N Engl J Med. 2004; 351:1962-1971.
4. Burton MJ, Holland MJ, Makalo P, et al. Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma endemic Gambian community. Lancet. 2005;365:1321-1328.
5. West ES, Munoz B, Mkocha H, et al. Mass treatment and the effect on the load of Chlamydia trachomatis infection in a trachoma-hyperendemic community. Invest Ophthalmol Vis Sci. 2005;46:83-87.
6. West SK, Munoz B, Mkocha H, et al. Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study. Lancet. 2005;366: 1296-1300.
7. Report of the Eighth Meeting of the WHO Alliance for the Global Elimination of blinding Trachoma. Report of a WHO Working Group. Geneva Switzerland: World Health Organization; 2004; WHO/PBD/GET/04.2.
8. Atik B, Thanh TT, Luong VQ, Lagree S, Dean D. Impact of annual targeted treatment on infectious trachoma and susceptibility to reinfection. JAMA. 2006;296:1488-1497.
9. Chidambaram JD, Alemayehu W, Melese M, et al. Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma. JAMA. 2006;295:1142-1146.
10. Gaynor BD, Miao Y, Cevallos V, et al. Eliminating trachoma in areas with limited disease. Emerg Infect Dis. 2003;9:596-598.
11. Broman, AT, Shum K, Munoz B, Duncan DD, West SK. Spatial clustering of ocular chlamydial infection over time following treatment, among households in a village in Tanzania. Invest Ophthalmol Vis Sci. 2006;47:99-104.
12. Thylefors B, Dawson CR, Jones BR, West SK, Taylor HR. A simple system for the assessment of trachoma and its complications. Bull World Health Org. 1987;65:477-483.
13. Hoechsmann A, Metcalfe N, Kanjaloti S, et al. Reduction of trachoma in the absence of antibiotic treatment: evidence from a population-based survey in Malawi. Ophthalmic Epidemiol. 2001;8:145-153.
14. Melese M, Chidambaram JD, Alemayehu W, et al. Feasibility of eliminating ocular Chlamydia trachomatis with repeat mass antibiotic treatments. JAMA. 2004;292:721-725.